Wealth Enhancement Advisory Services, LLC Monte Rosa Therapeutics, Inc. Call Options Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GLUE
# of Institutions
109Shares Held
53.5MCall Options Held
69.1KPut Options Held
22.4K-
Nea Management Company, LLC Timonium, MD7.69MShares$33.7 Million3.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.64MShares$29.1 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.66MShares$24.8 Million1.15% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$24.8 Million54.61% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$21.5 Million0.27% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $205M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...